Luxna Biotech Co., Ltd.

  • EN
  • JP

Luxna Biotech Co., Ltd.

  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Access
  • Contact
ルクサナバイオテク株式会社
  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Access
  • Contact

Notice│ News

  1. HOME
  2. News
  3. Notice

Notice of exclusive license agreement for artificially modified nucleic acid technology with Takeda Pharmaceutical Company Limited

  • 2022/02/24
  • Notice
Read

Notice of Fundraising

  • 2021/12/16
  • Notice
Read

Achieved milestonesbased on the technology license agreement with Aligos Therapeutics.

  • 2021/12/10
  • Notice
Read

We are selected as promising startup company by J-Startup KANSAI.

  • 2021/11/17
  • Notice
Read

Notice: Result of mid-term evaluation of the Spinal Cord Injury (SCI) Program of Cyclic Innovation for Clinical Empowerment (CiCLE) supported by Japan Agency for Medical Research and Development (AMED)

  • 2021/04/13
  • Notice
Read

Launched an animal experiments laboratory at Saito Bio Incubator

  • 2021/01/31
  • Notice

We got a prize in a presentation contest “Innovation Prize” sponsored by Boehringer Ingelheim Japan

  • 2020/09/23
  • Notice
Read

Collaboration Agreement concluded with Sumitomo Dainippon Pharma Co., Ltd.

  • 2020/04/24
  • Notice
Read

Notice of Fundraising

  • 2020/02/10
  • Notice
Read

Notice: Adoption of The 4th Cyclic Innovation for Clinical Empowerment(CiCLE) by Japan Agency for Medical Research and Development(AMED)

  • 2020/01/07
  • Notice
Read
  • 1
  • 2
  • 3
  • Next

Luxna Biotech Co., Ltd.

  • C907 9F Bldg. C, Techno-Alliance Complex, 2-8 Yamadaoka, Suita, Osaka 565-0871 JAPAN
  • TEL: +81(0)6-6170-1228
  • FAX: +81(0)6-6170-2207
  • MAIL: info@luxnabiotech.co.jp
  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Contact
  • Privacy Protection Policy
  • Site Map

Copyright © 2018 Luxna Biotech Co., Ltd. All Rights Reserved.